(Q33976007)

30 July 2017

1 reference

title

Homocysteine as atherothrombotic agent: is the bark worse than the bite? (English)

1 reference

30 July 2017

Ubbink JB

1

1 reference

30 July 2017

Delport R

series ordinal

2

1 reference

30 July 2017

publication date

1 July 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

16

1 reference

30 July 2017

issue

7-8

1 reference

30 July 2017

page(s)

672-674

1 reference

Hyperhomocysteinemia: an independent risk factor for vascular disease

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Maternal hyperhomocysteinemia: a risk factor for neural-tube defects?

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Homocysteine metabolism in pregnancies complicated by neural-tube defects.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

PATHOLOGICAL FINDINGS IN HOMOCYSTINURIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Morphologic Studies in a Patient with Homocystinuria due to 5,10-Methylenetetrahydrofolate Reductase Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Metabolism of sulfur-containing amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: methionine loading of non-transformed, transformed, proliferating, and quiescent cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Vitamin requirements for the treatment of hyperhomocysteinemia in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

The effect of a subnormal vitamin B-6 status on homocysteine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Formation of factor Va by atherosclerotic rabbit aorta mediates factor Xa-catalyzed prothrombin activation

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Serum total homocysteine and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Homocysteine and ischaemic heart disease in the Caerphilly cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

Homocysteine and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900356-7

7 January 2021

10.1016/S0899-9007(00)00356-7

Identifiers

DOI

1 reference

30 July 2017

1 reference